MedPath

Knowledge, Attitude and Perception of Pregnant Women Regarding Medications

Not yet recruiting
Conditions
Medications in Pregnancy
Registration Number
NCT06925672
Lead Sponsor
Rania Hassan Mostafa
Brief Summary

The goal of this observational study is to learn about the pregnant women's knowledge, attitude, and perception regarding the use of medications in pregnancy. The main question it aims to answer is:

What is the present knowledge, attitude, and perception of pregnant women regarding medication use?

Participants (pregnant women) already attending the antenatal clinic for routine follow-up will answer survey questions about their knowledge, attitude, and beliefs about medication use and restriction during pregnancy, as well as the source of their information.

Detailed Description

This is a descriptive cross-sectional study (survey) that will be held at Ain shams University Maternity Hospital.

The protocol approval will be sought from the ethical committee of department of Obstetrics and Gynecology, Ain Shams University.

• Data collection (the questionnaire): The study will use anonymous questionnaire; based upon previous similar studies.

The questionnaire comprises closed-ended questions categorized into four sections, along with fifth section consisting of statements pertaining to respondents' beliefs:

A. Section A (10 items) will contain information about the participant's socio-demographic and health related characteristics.

B. Section B (7 items) will assess their knowledge about medication use and restriction, during pregnancy.

C. Section C (4 items) will assess their attitude about medication. D. Section D (4 items) will assess the source of their information. E. Section E (9 statements) will assess their beliefs about medications use during pregnancy.

This questionnaire will be presented in its Arabic version and pre-tested on 15 pregnant women to evaluate the construct and content validity, as well as to determine if any modifications to wording are necessary. These participants will not be included in the final analysis.

The questionnaire will be distributed to pregnant women who attend the hospital for their routine antenatal check-up visits. In instances where women are unable to read or write, the principal investigator and attending house officer in the unit will provide assistance in reading and explaining the questions to facilitate the completion of the questionnaire.

* Data will be collected and recorded.

* Statistical analysis will be done accordingly.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Pregnant women attending the Ain shams University Maternity Hospital
Exclusion Criteria
  • Pregnant ladies refusing to participate in study.
  • Pregnant ladies needing immediate transport to emergency department.
  • Pregnant ladies needing immediate intervention.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knowledge of pregnant women regarding medication use and restriction in pregnancy.Once at recruitment

Degree of knowledge (information) that the pregnant women have about medication use and restriction during pregnancy, as well as the source of their information, as assessed by answering the questions in sections B and D in the questionnaire.

Secondary Outcome Measures
NameTimeMethod
Attitude of pregnant women regarding medication useOnce at recruitment

The attitudes of the pregnant women towards medication use during pregnancy, as assessed by answering the questions in section C in the questionnaire.

Perception and beliefs of pregnant women regarding medication use and restrictionOnce at recruitment

The beliefs of the pregnant women regarding medication use during pregnancy, as assessed by answering the questions in section E in the questionnaire.

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

Ain Shams University Maternity Hospital
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.